(Press-News.org) Collaboration focuses on City of Hope’s IL13RA2-EGFR targeting CAR T cell program addressing a type of fast-growing, aggressive brain cancer called glioblastoma multiforme.
The collaboration addresses solid tumor manufacturing bottlenecks and accelerates advancement toward clinical trials.
Los Angeles and South San Francisco, Calif. – City of Hope®, one of the largest and most advanced cancer research and treatment organizations in the United States, and Cellares, the first Integrated Development and Manufacturing Organization (IDMO), today announced a collaboration to evaluate automated manufacturing of City of Hope’s investigational gene-modified CAR T cell therapy targeting glioblastoma multiforme, an aggressive solid tumor brain cancer with limited treatment options.*
City of Hope is a leader in CAR T for glioblastoma and was the first to administer CAR T cell therapy locally in the brain through direct injection to the tumor site. City of Hope has deep expertise in developing gene-modified cell therapies for solid tumors and translating those discoveries into new treatments at lifesaving speeds. Its CARpool program, an IL13RA2-EGFR targeting CAR T cell therapy, targets glioblastoma, a disease with an estimated global incidence of approximately 300,000 new diagnoses annually.
Under the collaboration, City of Hope will evaluate Cellares’ Cell Shuttle™ automated manufacturing platform and Cell Q™ automated quality control system to enable reliable, high-throughput manufacturing and quality control of its CARpool program. By engaging at the preclinical stage, the collaboration will establish platform processes and analytics purpose-built for solid tumor CAR T programs, accelerating advancement into clinical trials while enabling scalable manufacturing to meet global patient demand.
“Glioblastoma remains one of the most challenging solid tumors to treat due to its highly immunosuppressive tumor microenvironment, antigen heterogeneity and limited persistence of engineered T cells,” said Christine Brown, Ph.D., deputy director of the T Cell Therapeutics Research Laboratories at City of Hope. “Advancing CAR T therapies in this setting requires not only rigorous translational science but also highly controlled and reproducible manufacturing. We are excited to incorporate automation early in development to standardize processes and analytics, enabling the consistency required for effective clinical translation.”
“Manual, fragmented manufacturing and quality control cannot meet the scale required for large solid tumor patient populations,” said Fabian Gerlinghaus, co-founder and chief executive officer of Cellares. “By collaborating with City of Hope, we will remove these bottlenecks through automation, enabling reproducible manufacturing, lowering failure rates, and expanding patient access at commercial scale.”
* City of Hope licensed the IL13-CAR technology to Mustang Bio Inc. City of Hope is entitled to royalties from and holds equity in the company. Dr. Brown is an inventor of the technology, is entitled to a portion of the royalties and holds equity in the company.
About City of Hope
City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. Founded in 1913, City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in the United States, and one of the leading research centers for diabetes and other life-threatening illnesses. City of Hope research has been the basis for numerous breakthrough cancer medicines, as well as human synthetic insulin and monoclonal antibodies. With an independent, National Cancer Institute-designated comprehensive cancer center that is ranked among the nation’s top cancer centers by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, Orange County, California, campus, a network of clinical care locations across Southern California and cancer treatment centers and outpatient facilities in the Atlanta, Chicago and Phoenix areas. City of Hope’s affiliated group of organizations includes Translational Genomics Research Institute and AccessHopeTM. For more information about City of Hope, follow us on Facebook, X, YouTube, Instagram and LinkedIn.
About Cellares
Cellares is the first Integrated Development and Manufacturing Organization (IDMO), providing global cell therapy development and manufacturing services through an Industry 4.0 approach to the mass manufacture of the living drugs of the 21st century. The company enables biopharmaceutical partners to develop, scale, and commercialize cell therapies with the capacity, reliability, and economics required to meet total patient demand.
Cellares’ fully automated platforms - Cell Shuttle™ for end-to-end cell therapy manufacturing and Cell Q™ for automated in-process and release quality control - are deployed across its network of IDMO Smart Factories worldwide. These technologies deliver industry-leading manufacturing economics, higher process success rates, and the ability to produce up to 10× more cell therapy batches than conventional CDMOs with comparable footprint and headcount, resulting in the lowest cost of manufacturing in the industry.
Headquartered in South San Francisco, California, Cellares operates its first commercial-scale IDMO Smart Factory in Bridgewater, New Jersey, with additional facilities under construction in Europe and Japan. Through its global manufacturing network, Cellares is purpose-built to support both clinical and commercial programs and to expand access to life-saving cell therapies worldwide. For more information, visit www.cellares.com and follow Cellares on LinkedIn.
Cellares Contacts
Business Development:
bd@cellares.com
Investors:
ir@cellares.com
Media:
pr@cellares.com
City of Hope Contact
Media:
zlogsdon@coh.org
END
City of Hope and Cellares to automate manufacturing of solid tumor CAR T cell therapy
2026-01-08
ELSE PRESS RELEASES FROM THIS DATE:
Short-circuiting pancreatic cancer
2026-01-08
Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It’s also the most common form of the disease. Potential treatments typically target a key mutated oncogene called KRAS. In some cases, PDAC tumors with these mutations have resisted therapeutic efforts. However, combination therapies involving alternative drug targets may one day help clinicians overwhelm these defenses.
In 2023, Cold Spring Harbor Laboratory (CSHL) Professor Adrian Krainer’s lab discovered ...
Groundbreaking mapping: how many ghost particles all the Milky Way’s stars send towards Earth
2026-01-08
They’re called ghost particles for a reason. They’re everywhere – trillions of them constantly stream through everything: our bodies, our planet, even the entire cosmos – without us noticing. These so-called neutrinos are elementary particles that are invisible, incredibly light, and interact only rarely with other matter. The weakness of their interactions makes neutrinos extremely difficult to detect. But when scientists do manage to capture them, they can offer extraordinary insights into the universe.
Neutrinos ...
JBNU researchers propose hierarchical porous copper nanosheet-based triboelectric nanogenerators
2026-01-08
In recent years, two-dimensional (2D) single-crystalline metal nanosheets have emerged as a promising next-generation platform for self-powered electronics. However, their potential for triboelectric nanogenerators (TENGs)—a promising energy-harvesting technology—remains largely untapped, mainly due to their low current output and limited durability.
In an innovative breakthrough, a team of researchers led by Associate Professor Tae-Wook Kim from the Department of Flexible and Printable Electronics, Jeonbuk National University, Republic of Korea, has redesigned the internal structure of 2D metal nanosheets to overcome the existing ...
A high-protein diet can defeat cholera infection
2026-01-08
Cholera, a severe bacterial infection that causes diarrhea and kills if untreated, can be defeated with a diet high in protein, according to a new study from UC Riverside.
Specifically, the study found that diets high in casein, the main protein in milk and cheese, as well as wheat gluten, could make a dramatic difference in the amount of cholera bacteria able to infect the gut.
“I wasn’t surprised that diet could affect the health of someone infected with the bacteria. But the magnitude of the effect surprised me,” said Ansel Hsiao, UCR associate professor of microbiology and plant pathology and senior author of the study published in Cell Host ...
A more accurate way of calculating the value of a healthy year of life
2026-01-08
Decades of advances in medical technology and public health are causing global populations to age. While achieving longer lives is certainly a net positive, this demographic shift is placing an ever-growing strain on national budgets, and many countries around the world are struggling to maintain sustainable healthcare systems. Japan, which boasts as one of the world’s longest life expectancies, faces an especially big hurdle, with healthcare expenses projected to nearly double by 2040.
To meet this challenge, governments must ...
What causes some people’s gut microbes to produce high alcohol levels?
2026-01-08
Researchers at University of California San Diego, Mass General Brigham, and their colleagues have identified specific gut bacteria and metabolic pathways that drive alcohol production in patients with auto-brewery syndrome (ABS). The rare and often misunderstood condition causes people to experience intoxication without drinking alcohol. The study was published in Nature Microbiology on January 8, 2026.
ABS occurs when gut microbes break down carbohydrates and convert them to ethanol (the alcohol found ...
Global study reveals widespread burning of plastic for heating and cooking
2026-01-08
A new Curtin University-led study has shed new light on the widespread number of households in developing countries burning plastic as an everyday energy source, uncovering serious international health, social equality and environmental concerns.
Published in Nature Communications, the research surveyed more than 1000 respondents across 26 countries who work closely with low-income urban neighbourhoods, such as researchers, government workers and community leaders.
One in three respondents said they were aware of households burning plastic, with many personally witnessing ...
MIT study shows pills that communicate from the stomach could improve medication adherence
2026-01-08
CAMBRIDGE, MA -- In an advance that could help ensure people are taking their medication on schedule, MIT engineers have designed a pill that can report when it has been swallowed.
The new reporting system, which can be incorporated into existing pill capsules, contains a biodegradable radio frequency antenna. After it sends out the signal that the pill has been consumed, most components break down in the stomach while a tiny RF chip passes out of the body through the digestive tract.
This type of system could ...
Searching for the centromere: diversity in pathways key for cell division
2026-01-08
Osaka, Japan – Despite the immense amount of genetic material present in each cell, around three billion base pairs in humans, this material needs to be accurately divided in two and allocated in equal quantities. The centromere, located in the middle of each chromosome, is known as the site where cellular equipment attaches to divide chromosomes successfully, but the specific mechanisms behind this remain unknown.
In a major new study reported in The EMBO Journal, researchers at The University of Osaka have identified an additional pathway by which the DNA-packaging histone CENP-A associates with and specifies the location ...
Behind nature’s blueprints
2026-01-08
Inspired by biological systems, materials scientists have long sought to harness self-assembly to build nanomaterials. The challenge: the process seemed random and notoriously difficult to predict. Now, researchers from the Institute of Science and Technology Austria (ISTA) and Brandeis University have uncovered geometric rules that act as a master control panel for self-assembling particles. The results, which could find applications ranging from protein design to synthetic nanomachines, were published in Nature Physics.
Life is the ultimate nanotechnologist. Biology has long fascinated physicists with its ability to build complex molecular machines and structures from ...